Renalytix
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Renalytix generated cash of -$30,111,000, which is more than the previous year. Cash used in financing activities reached the amount of $10,250,000 last year. Net change in cash is therefore -$20,002,000.
Cash Flow
| 2019 | -3.99M | -13.04M | 26.24M |
|---|---|---|---|
| 2020 | -10.06M | -485K | 16.54M |
| 2021 | -24.63M | -741K | 77.23M |
| 2022 | -45.74M | -694K | 25.51M |
| 2023 | -32.67M | 0 | 15.11M |
| 2024 | -30.11M | -4K | 10.25M |
RNLX Cash Flow Statement (2019 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 24.68M | 41.33M | 65.15M | 13.29M | 7.29M | 82K |
Operating activities | ||||||
Net income | -33.45M | -46.22M | -49.62M | -35.78M | -10.61M | -6.51M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 364K | 2.49M | 2.61M | 2.09M | -485K | 1.12M |
Stock-based compensation expense | 1.71M | 2.93M | 4.62M | 2.18M | 1.15M | 532K |
| Deferred income tax benefit | 1.71M | 2.93M | 4.62M | 2.18M | 1.15M | 532K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 54K | 125K | -307K | -594K | -355K | 0 |
Inventories | 0 | 442K | -807K | -27K | -326K | 0 |
Accounts payable | 106K | 80K | 1.41M | 782K | 355K | 302.95K |
Cash generated by operating activities | -30.11M | -32.67M | -45.74M | -24.63M | -10.06M | -3.99M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | -1.33M | -973K | -4.96M |
Investments In Property Plant And Equipment | -4K | 0 | -694K | -1.63M | -1.31M | -13.04M |
Acquisitions Net | 0 | 0 | 0 | 472K | -122K | 11.98M |
Cash generated by investing activities | -4K | 0 | -694K | -741K | -485K | -13.04M |
Financing activities | ||||||
Common Stock Issued | 13.62M | 20.55M | 9.21M | 77.23M | 16.37M | 29.11M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.66M | -3.18M | 18.02M | -202K | -255K | -1.06M |
Cash used in financing activities | 10.25M | 15.11M | 25.51M | 77.23M | 16.54M | 26.24M |
Net Change In Cash | -20.00M | -16.65M | -23.82M | 51.86M | 5.99M | 9.20M |
Cash at end of period | 4.68M | 24.68M | 41.33M | 65.15M | 13.29M | 9.28M |
| Data source | Data source | Data source | Data source | Data source |